Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epitope‐based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study
Muhammad Tahir ul Qamar, Saman Saleem, Usman Ali Ashfaq, et al.
Journal of Translational Medicine (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 179

Showing 1-25 of 179 citing articles:

Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants
Muhammad Tahir ul Qamar, Safar M. Alqahtani, Mubarak A. Alamri, et al.
Journal of Pharmaceutical Analysis (2020) Vol. 10, Iss. 4, pp. 313-319
Open Access | Times Cited: 1029
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan, Sam Afkhami, Fiona Smaill, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 10, pp. 615-632
Open Access | Times Cited: 1022
Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV
Vargab Baruah, Sujoy Bose
Journal of Medical Virology (2020) Vol. 92, Iss. 5, pp. 495-500
Open Access | Times Cited: 274
Structure-based drug designing and immunoinformatics approach for SARS-CoV-2
Pritam Kumar Panda, N. Arul Murugan, Paritosh Patel, et al.
Science Advances (2020) Vol. 6, Iss. 28
Open Access | Times Cited: 174
Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches
Rong Dong, Zhugang Chu, Fuxun Yu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 174
Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2 etiologic agent of global pandemic COVID-19: an in silico approach
M. Shaminur Rahman, M. Nazmul Hoque, M. Rafiul Islam, et al.
PeerJ (2020) Vol. 8, pp. e9572-e9572
Open Access | Times Cited: 146
Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches
Muhammad Tahir ul Qamar, Abdur Rehman, Kishver Tusleem, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0244176-e0244176
Open Access | Times Cited: 135
Computational Design, Expression, and Characterization of a Plasmodium falciparum Multi-epitope, Multi-stage Vaccine Candidate (PfCTMAG)
Joel M. Chick, Nadege N Abongdia, Robert Adamu Shey, et al.
Heliyon (2025) Vol. 11, Iss. 2, pp. e42014-e42014
Open Access | Times Cited: 1
SARS-CoV-2 Vaccine Development: Current Status
Gregory A. Poland, Inna G. Ovsyannikova, Stephen N. Crooke, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 10, pp. 2172-2188
Open Access | Times Cited: 113
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches
Ashkan Safavi, Amirhosein Kefayat, Elham Mahdevar, et al.
Vaccine (2020) Vol. 38, Iss. 48, pp. 7612-7628
Open Access | Times Cited: 108
Fragment Molecular Orbital Based Interaction Analyses on COVID-19 Main Protease − Inhibitor N3 Complex (PDB ID: 6LU7)
Ryo Hatada, Koji Okuwaki, Yuji Mochizuki, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 7, pp. 3593-3602
Open Access | Times Cited: 106
The novel SARS-CoV-2 pandemic: Possible environmental transmission, detection, persistence and fate during wastewater and water treatment
Sanjeeb Mohapatra, N. Gayathri Menon, Gayatree Mohapatra, et al.
The Science of The Total Environment (2020) Vol. 765, pp. 142746-142746
Open Access | Times Cited: 99
Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome
Stephen N. Crooke, Inna G. Ovsyannikova, Richard B. Kennedy, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 96
Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach
Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, et al.
Journal of Molecular Liquids (2020) Vol. 320, pp. 114493-114493
Open Access | Times Cited: 94
Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach
Ishtiaque Ahammad, Samia Sultana Lira
International Journal of Biological Macromolecules (2020) Vol. 162, pp. 820-837
Open Access | Times Cited: 89
Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2
Muhammad Tahir ul Qamar, Farah Shahid, Sadia Aslam, et al.
Infectious Diseases of Poverty (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 84
A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on body weight in healthy subjects aged 16 years and above
Haitham Jahrami, Joud Zanabili, Cain C. T. Clark, et al.
European Journal of Nutrition (2020) Vol. 59, Iss. 6, pp. 2291-2316
Closed Access | Times Cited: 83
Multiepitope-Based Subunit Vaccine Design and Evaluation against Respiratory Syncytial Virus Using Reverse Vaccinology Approach
Muhammad Tahir ul Qamar, Zeeshan Shokat, Iqra Muneer, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 288-288
Open Access | Times Cited: 81
Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2
Hongzhi Chen, Lingli Tang, Xinling Yu, et al.
Infectious Diseases of Poverty (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 79
Development of multi-epitope peptide-based vaccines against SARS-CoV-2
Hui Xuan Lim, Jianhua Lim, Seyed Davoud Jazayeri, et al.
Biomedical Journal (2020) Vol. 44, Iss. 1, pp. 18-30
Open Access | Times Cited: 72
Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2
Lin Li, Ting Sun, Yufei He, et al.
Virus Research (2020) Vol. 288, pp. 198082-198082
Open Access | Times Cited: 69
Peptides for Vaccine Development
Ian W. Hamley
ACS Applied Bio Materials (2022) Vol. 5, Iss. 3, pp. 905-944
Open Access | Times Cited: 60
Immunoinformatics-Aided Design of a Peptide Based Multiepitope Vaccine Targeting Glycoproteins and Membrane Proteins against Monkeypox Virus
Nahid Akhtar, Vikas Kaushik, Ravneet Kaur Grewal, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2374-2374
Open Access | Times Cited: 43
Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms
Ameneh Jafari, Fahima Danesh Pouya, Zahra Niknam, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 6, pp. 4943-4957
Open Access | Times Cited: 41
Novel In Silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modifications
H. Al Tbeishat
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top